In his latest video interview EPDT’s Editor-in-Chief Mike Green talks with Andreas Lifvendahl, CEO of Percepio about the emerging era of software-defined medical devices and how consistent behaviour can be maintained on an ongoing basis.
Clinical trials are an ideal opportunity not only to validate clinical outcomes but also to understand software behaviour under real operating conditions.
“Today it’s a lot of ad hoc debugging… then you remove the printf’s and alike completely, and then you’re basically flying blind from that point on. … But development never stops. We are only a small piece of a much larger puzzle—but it’s a puzzle that is rapidly growing and evolving” says Lifvendahl, CEO at Percepio.
